​

Akari Therapeutics Ownership | Who Owns Akari Therapeutics?

OverviewForecastRevenueFinancialsChart

Akari Therapeutics Ownership Summary

Akari Therapeutics is owned by 7435.62% institutional investors, 31.48% insiders. Hightower advisors is the largest institutional shareholder, holding 503.53% of AKTX shares. LUX IM Global Medtech HX is the top mutual fund, with 0.03% of its assets in Akari Therapeutics shares.

AKTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAkari Therapeutics7435.62%31.48%-7367.10%
SectorHealthcare Stocks 41.88%10.83%47.29%
IndustryBiotech Stocks 44.05%10.78%45.17%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Hightower advisors79.24K503.53%$80.03K
Omnia family wealth28.44K180.73%$28.72K
Cerity partners23.64K150.25%$23.88K
Independent advisor alliance10.89K69.19%$11.00K
Sabby management179.78K32.93%$210.33K
Palo alto investors lp146.02K26.75%$170.83K
Cresset asset management18.41K3.37%$21.54K
Accent capital management10.00K1.83%$11.70K
Newedge advisors6.80K1.25%$7.96K
Eversource wealth advisors44.000.28%$44.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sabby management179.78K0.38%$210.33K
Palo alto investors lp146.02K0.04%$170.83K
Omnia family wealth28.44K0.01%$28.72K
Accent capital management10.00K0.01%$11.70K
Independent advisor alliance10.89K0.00%$11.00K
Hightower advisors79.24K0.00%$80.03K
Cresset asset management18.41K0.00%$21.54K
Newedge advisors6.80K-$7.96K
Cornerstone planning group7.00-$285.00
Eversource wealth advisors44.00-$44.00

Top Buyers

HolderShares% AssetsChange
Sabby management179.78K0.38%179.78K
Independent advisor alliance10.89K0.00%10.89K
Newedge advisors6.80K-6.80K
Cornerstone planning group7.00-2.00
Cerity partners23.64K--

Top Sellers

HolderShares% AssetsChange
Omnia family wealth28.44K0.01%-34.25K
Eversource wealth advisors44.00--4.33K
Truvestments capital50.00--
Palo alto investors lp146.02K0.04%-
Accent capital management10.00K0.01%-

New Positions

HolderShares% AssetsChangeValue
Sabby management179.78K0.38%179.78K$210.33K
Independent advisor alliance10.89K0.00%10.89K$11.00K
Newedge advisors6.80K-6.80K$7.96K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251614.29%1,170,067112.45%7,43573.05%620.00%350.00%
Jun 30, 20251550.00%550,74080.99%10032469.88%5-3200.00%
Mar 31, 202510-28.57%304,298-5.73%-30.53%--100.00%1-
Dec 31, 20241440.00%322,78378.02%1244.43%650.00%1-
Sep 30, 202410-181,3210.63%-81.26%4-20.00%--

Top Mutual Funds Shareholders

HolderShares% HoldingChange
LUX IM Global Medtech HX10.26K0.03%-
Fidelity Nasdaq Composite Index1.51K0.01%-
RiverNorth Marketplace Lending Corp1.10K0.00%-
RiverNorth Opportunities509.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 21, 2025Gaslightwala Abizer CEOBuy$9.40K
Aug 25, 2025Gaslightwala Abizer CEOBuy$2.70K
Aug 22, 2025Gaslightwala Abizer CEOBuy$7.44K
Jun 24, 2025Gaslightwala Abizer President & CEOBuy$6.04K
Jun 23, 2025Gaslightwala Abizer President & CEOBuy$1.08K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q33-
2025 Q24-
2025 Q1--
2024 Q4--

AKTX Ownership FAQ

Who Owns Akari Therapeutics?

Akari Therapeutics shareholders are primarily institutional investors at 7435.62%, followed by 31.48% insiders and -7367.10% retail investors. The average institutional ownership in Akari Therapeutics's industry, Biotech Stocks , is 44.05%, which Akari Therapeutics exceeds.

Who owns the most shares of Akari Therapeutics?

Akari Therapeutics’s largest shareholders are Hightower advisors (79.24K shares, 503.53%), Omnia family wealth (28.44K shares, 180.73%), and Cerity partners (23.64K shares, 150.25%). Together, they hold 834.51% of Akari Therapeutics’s total shares outstanding.

Does Blackrock own Akari Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Akari Therapeutics.

Who is Akari Therapeutics’s biggest shareholder by percentage of total assets invested?

Sabby management is Akari Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 179.78K Akari Therapeutics shares, valued at 210.33K$.

Who is the top mutual fund holder of Akari Therapeutics shares?

LUX IM Global Medtech HX is the top mutual fund holder of Akari Therapeutics shares, with 0.03% of its total shares outstanding invested in 10.26K Akari Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools